3-155853486-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004733.4(SLC33A1):​c.512A>G​(p.Asp171Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0653 in 1,613,918 control chromosomes in the GnomAD database, including 4,454 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.078 ( 586 hom., cov: 32)
Exomes 𝑓: 0.064 ( 3868 hom. )

Consequence

SLC33A1
NM_004733.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 3.63

Publications

23 publications found
Variant links:
Genes affected
SLC33A1 (HGNC:95): (solute carrier family 33 member 1) The protein encoded by this gene is required for the formation of O-acetylated (Ac) gangliosides. The encoded protein is predicted to contain 6 to 10 transmembrane domains, and a leucine zipper motif in transmembrane domain III. Defects in this gene have been reported to cause spastic paraplegia autosomal dominant type 42 (SPG42) in one Chinese family, but not in similar patients of European descent. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010]
SLC33A1 Gene-Disease associations (from GenCC):
  • Huppke-Brendel syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • hereditary spastic paraplegia 42
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Illumina, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015049577).
BP6
Variant 3-155853486-T-C is Benign according to our data. Variant chr3-155853486-T-C is described in ClinVar as Benign. ClinVar VariationId is 259528.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.17 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC33A1NM_004733.4 linkc.512A>G p.Asp171Gly missense_variant Exon 1 of 6 ENST00000643144.2 NP_004724.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC33A1ENST00000643144.2 linkc.512A>G p.Asp171Gly missense_variant Exon 1 of 6 NM_004733.4 ENSP00000496241.1
ENSG00000284952ENST00000643876.1 linkn.512A>G non_coding_transcript_exon_variant Exon 1 of 10 ENSP00000495323.1

Frequencies

GnomAD3 genomes
AF:
0.0780
AC:
11860
AN:
152000
Hom.:
583
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.110
Gnomad AMI
AF:
0.0888
Gnomad AMR
AF:
0.0592
Gnomad ASJ
AF:
0.0410
Gnomad EAS
AF:
0.181
Gnomad SAS
AF:
0.172
Gnomad FIN
AF:
0.0528
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0541
Gnomad OTH
AF:
0.0809
GnomAD2 exomes
AF:
0.0829
AC:
20842
AN:
251404
AF XY:
0.0850
show subpopulations
Gnomad AFR exome
AF:
0.114
Gnomad AMR exome
AF:
0.0711
Gnomad ASJ exome
AF:
0.0380
Gnomad EAS exome
AF:
0.187
Gnomad FIN exome
AF:
0.0532
Gnomad NFE exome
AF:
0.0558
Gnomad OTH exome
AF:
0.0587
GnomAD4 exome
AF:
0.0640
AC:
93546
AN:
1461800
Hom.:
3868
Cov.:
32
AF XY:
0.0667
AC XY:
48515
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.113
AC:
3779
AN:
33478
American (AMR)
AF:
0.0701
AC:
3133
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0391
AC:
1022
AN:
26136
East Asian (EAS)
AF:
0.168
AC:
6684
AN:
39698
South Asian (SAS)
AF:
0.155
AC:
13366
AN:
86258
European-Finnish (FIN)
AF:
0.0543
AC:
2899
AN:
53380
Middle Eastern (MID)
AF:
0.0463
AC:
267
AN:
5768
European-Non Finnish (NFE)
AF:
0.0523
AC:
58125
AN:
1111966
Other (OTH)
AF:
0.0707
AC:
4271
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
5454
10907
16361
21814
27268
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2350
4700
7050
9400
11750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0781
AC:
11874
AN:
152118
Hom.:
586
Cov.:
32
AF XY:
0.0808
AC XY:
6006
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.110
AC:
4577
AN:
41492
American (AMR)
AF:
0.0594
AC:
908
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0410
AC:
142
AN:
3466
East Asian (EAS)
AF:
0.180
AC:
930
AN:
5164
South Asian (SAS)
AF:
0.171
AC:
824
AN:
4816
European-Finnish (FIN)
AF:
0.0528
AC:
559
AN:
10588
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0541
AC:
3677
AN:
67996
Other (OTH)
AF:
0.0796
AC:
168
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
540
1080
1621
2161
2701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0619
Hom.:
1571
Bravo
AF:
0.0783
TwinsUK
AF:
0.0510
AC:
189
ALSPAC
AF:
0.0454
AC:
175
ESP6500AA
AF:
0.100
AC:
441
ESP6500EA
AF:
0.0512
AC:
440
ExAC
AF:
0.0850
AC:
10325
Asia WGS
AF:
0.151
AC:
526
AN:
3478
EpiCase
AF:
0.0525
EpiControl
AF:
0.0537

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Spastic paraplegia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Huppke-Brendel syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary spastic paraplegia 42 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
18
DANN
Benign
0.30
DEOGEN2
Benign
0.051
T;T;T;.
Eigen
Benign
-0.11
Eigen_PC
Benign
0.0093
FATHMM_MKL
Benign
0.070
N
LIST_S2
Benign
0.0
.;.;T;T
MetaRNN
Benign
0.0015
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.1
N;N;N;.
PhyloP100
3.6
PrimateAI
Benign
0.47
T
PROVEAN
Benign
2.1
N;.;N;.
REVEL
Benign
0.13
Sift
Benign
1.0
T;.;T;.
Sift4G
Benign
1.0
T;.;T;.
Vest4
0.031
ClinPred
0.0034
T
GERP RS
5.4
PromoterAI
0.0039
Neutral
Varity_R
0.047
gMVP
0.41
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3804769; hg19: chr3-155571275; COSMIC: COSV63947176; COSMIC: COSV63947176; API